Forty-three squamous cell carcinomas of the head and neck region were
in vivo labelled with the thymidine analogue iododeoxyuridine. Combine
d flow cytometric (FCM) and immunohistochemical (IHC) analysis was per
formed, and the following parameters calculated: labelling index (LI),
S-phase time (T(S)) and potential tumor doubling time (T(pot)). Compl
ete FCM and IHC analyses could successfully be performed in 31 cases,
showing a median LI of 13.6% with FCM and 9.1% with IHC. A correlation
achieved between LI/FCM and LI/IHC was due to the aneuploid cases, wh
ereas the diploid cases showed no such correlation. Data indicated tha
t T(pot) calculated with LI from IHC (T(pot)/IHC) might be a prognosti
c factor, in contrast to T(pot) determined using LI/FCM.